A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer’s Disease and Frontotemporal Dementia Disease Modeling
Authors:
- Sonia Sanz MuñozSonia Sanz Muñoz
- Martin EngelMEMartin Engel
- Rachelle BalezRBRachelle Balez
- Dzung Do-HaDDDzung Do-Ha
- Mauricio Castro Cabral-Da-SilvaMCMauricio Castro Cabral-Da-Silva
- Damian HernándezDHDamian Hernández
- Tracey BergTBTracey Berg
- Jennifer A. FifitaJFJennifer A. Fifita
- Natalie GrimaNGNatalie Grima
- Shu YangSYShu Yang
- Ian P. BlairIBIan P. Blair
- Garth NicholsonGNGarth Nicholson
Open Access
Abstract
The study of neurodegenerative diseases using pluripotent stem cells requires new methods to assess neurodevelopment and neurodegeneration of specific neuronal subtypes. The cholinergic system, characterized by its use of the neurotransmitter acetylcholine, is one of the first to degenerate in Alzheimer’s disease and is also affected in frontotemporal dementia. We developed a differentiation protocol to generate basal forebrain-like cholinergic neurons (BFCNs) from induced pluripotent stem cells (iPSCs) aided by the use of small molecule inhibitors and growth factors. Ten iPSC lines were successfully differentiated into BFCNs using this protocol. The neuronal cultures were characterised through RNA and protein expression, and functional analysis of neurons was confirmed by whole-cell patch clamp. We have developed a reliable protocol using only small molecule inhibitors and growth factors, while avoiding transfection or cell sorting methods, to achieve a BFCN culture that expresses the characteristic markers of cholinergic neurons.Keywords
All Related Versions
Funding Information
- National Health and Medical Research Council (APP1135720, APP1071250, APP1095215, 1154389)
This publication has 40 references indexed in Scilit:
- Current and future treatments for Alzheimer’s diseaseTherapeutic Advances in Neurological Disorders, 2012
- Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer’s diseaseJournal of Neural Transmission, 2012
- A novel function of the proneural factor Ascl1 in progenitor proliferation identified by genome-wide characterization of its targetsGenes & Development, 2011
- The Controlled Generation of Functional Basal Forebrain Cholinergic Neurons from Human Embryonic Stem CellsStem Cells, 2011
- The transcription factor Foxg1 regulates the competence of telencephalic cells to adopt subpallial fates in miceDevelopment, 2010
- Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cellsDevelopment, 2009
- Cholinergic system during the progression of Alzheimer’s disease: therapeutic implicationsExpert Review of Neurotherapeutics, 2008
- The proneural determinant MASH1 regulates forebrainDlx1/2expression through the I12b intergenic enhancerDevelopment, 2007
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982